Ke Xu - Concepedia

Author

Ke Xu

Affiliated Hospital of Southwest Medical University ORCID

Also Known As

K. Xu, Kang‐Cheng Xu, Ke Ping Xu, Ke Xu, Xu Ke, Xu, Ke, Yuanyong Wang

105

Publications

1.6K

Citations

H-Index

Concepts

All Affiliations

Affiliated Hospital of Southwest Medical University Southwest Medical University First People's Hospital of Chongqing Sichuan Cancer Hospital University of Electronic Science and Technology of China

About

Ke Xu is an author at Affiliated Hospital of Southwest Medical University specializing in cell biology, medicine, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	197
2	Engineering	2	2	65
3	Health Sciences	1	1	16
4	Natural Sciences	1	1	24
5	Allergy	1	1	15

Ke Xu

Publications

1.4K

Citations

H-Index

Page 1

	Year	Citations
T-cell exhaustion signatures characterize the immune landscape and predict HCC prognosis via integrating single-cell RNA-seq and bulk RNA-sequencing Hao Chi, Songyun Zhao, Jinyan Yang, Frontiers in Immunology	2023	141
A novel anoikis-related gene signature predicts prognosis in patients with head and neck squamous cell carcinoma and reveals immune infiltration Hao Chi, Puyu Jiang, Ke Xu, Frontiers in Genetics	2022	124
Curcumin-Mediated Neuroprotection Against Amyloid-β-Induced Mitochondrial Dysfunction Involves the Inhibition of GSK-3β Han‐Chang Huang, Ke Xu, Zhao-Feng Jiang Journal of Alzheimer s Disease	2012	98
Curcumin attenuates amyloid-β-induced tau hyperphosphorylation in human neuroblastoma SH-SY5Y cells involving PTEN/Akt/GSK-3β signaling pathway Han‐Chang Huang, Tang Di, Ke Xu, Journal of Receptors and Signal Transduction	2013	96
Identification and validation of neurotrophic factor-related gene signatures in glioblastoma and Parkinson’s disease Songyun Zhao, Hao Chi, Qian Yang, Frontiers in Immunology	2023	79
Cuprotosis Programmed-Cell-Death-Related lncRNA Signature Predicts Prognosis and Immune Landscape in PAAD Patients Hao Chi, Gaoge Peng, Rui Wang, Cells Paad DataApoptosisImmunologyImmune LandscapePathology	2022	65
Identification and validation of neurotrophic factor-related genes signature in HNSCC to predict survival and immune landscapes Gaoge Peng, Hao Chi, Xinrui Gao, Frontiers in Genetics	2022	60
PD-1 inhibitors plus anti-angiogenic therapy with or without intensity-modulated radiotherapy for advanced hepatocellular carcinoma: A propensity score matching study Ke Su, Lu Guo, Wenqiong Ma, Frontiers in Immunology	2022	52
PD-L1 expression on circulating tumor cells can be a predictive biomarker to PD-1 inhibitors combined with radiotherapy and antiangiogenic therapy in advanced hepatocellular carcinoma Ke Su, Lu Guo, Kun He, Frontiers in Oncology	2022	45
Heat-shock protein 90α is a potential prognostic and predictive biomarker in hepatocellular carcinoma: a large-scale and multicenter study Ke Su, Pan Wang, Kun He, Hepatology International	2022	42

Page 1